These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25601329)

  • 1. The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence.
    Montesanto A; Geracitano S; Garasto S; Fusco S; Lattanzio F; Passarino G; Corsonello A
    Curr Drug Targets; 2016; 17(4):428-38. PubMed ID: 25601329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating Genomic Advances to Physical Therapist Practice: A Closer Look at the Nature and Nurture of Common Diseases.
    Curtis CL; Goldberg A; Kleim JA; Wolf SL
    Phys Ther; 2016 Apr; 96(4):570-80. PubMed ID: 26637647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk factors for type 2 diabetes: insights from the emerging genomic evidence.
    Ntzani EE; Kavvoura FK
    Curr Vasc Pharmacol; 2012 Mar; 10(2):147-55. PubMed ID: 22239624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-based prediction of common diseases: advances and prospects.
    Janssens AC; van Duijn CM
    Hum Mol Genet; 2008 Oct; 17(R2):R166-73. PubMed ID: 18852206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-2 diabetes-associated variants with cross-trait relevance: Post-GWAs strategies for biological function interpretation.
    Frau F; Crowther D; Ruetten H; Allebrandt KV
    Mol Genet Metab; 2017 May; 121(1):43-50. PubMed ID: 28385534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding multiple sclerosis: an update on genomics and future directions.
    Oksenberg JR
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):11-9. PubMed ID: 24289837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits.
    So HC; Sham PC
    Bioinformatics; 2017 Mar; 33(6):886-892. PubMed ID: 28065900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.
    Marian AJ; van Rooij E; Roberts R
    J Am Coll Cardiol; 2016 Dec; 68(25):2831-2849. PubMed ID: 28007145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics and large scale phenotypic databases.
    Winkelmann BR
    Pharmacogenomics; 2001 Feb; 2(1):3-5. PubMed ID: 11258195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to establish genetic causality.
    McNally EM; George AL
    Trends Cardiovasc Med; 2015 Oct; 25(7):646-52. PubMed ID: 25864169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of cardiovascular diseases: lessons learned from a decade of genomics research in Iceland.
    Arnar DO; Andersen K; Thorgeirsson G
    Scand Cardiovasc J; 2016; 50(5-6):260-265. PubMed ID: 27572422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Common, Complex Coronary Artery Disease.
    Musunuru K; Kathiresan S
    Cell; 2019 Mar; 177(1):132-145. PubMed ID: 30901535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions.
    Pasipoularides A
    J Cardiovasc Transl Res; 2015 Dec; 8(9):506-27. PubMed ID: 26545598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of type 2 diabetes and potential clinical implications.
    Kwak SH; Park KS
    Arch Pharm Res; 2013 Feb; 36(2):167-77. PubMed ID: 23377708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors.
    LeBlanc M; Zuber V; Andreassen BK; Witoelar A; Zeng L; Bettella F; Wang Y; McEvoy LK; Thompson WK; Schork AJ; Reppe S; Barrett-Connor E; Ligthart S; Dehghan A; Gautvik KM; Nelson CP; Schunkert H; Samani NJ; ; Ridker PM; Chasman DI; Aukrust P; Djurovic S; Frigessi A; Desikan RS; Dale AM; Andreassen OA
    Circ Res; 2016 Jan; 118(1):83-94. PubMed ID: 26487741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclassification of genetic-based risk predictions as GWAS data accumulate.
    Krier J; Barfield R; Green RC; Kraft P
    Genome Med; 2016 Feb; 8(1):20. PubMed ID: 26884246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.